Stock listing

BCBA:GILD Gilead Sciences, Inc. Acciones

Argentine listing (BCBA) of Gilead Sciences, Inc. · home listing NASDAQ:GILD

Follow Gilead Sciences, Inc. into a list and get an email when it puts out news.

Home listing price · NASDAQ:GILD

$156.19 USD -1.18 (-0.7%)

Close on Oct 16, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:GILD

Gilead Sciences, Inc. logo
Ticker
BCBA:GILD
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
BCBA
Currency
ARS

What changed lately

Calls

Upcoming

  • Gilead Sciences (NASDAQ:GILD) Q3 2026 Earnings Call

    Thu, Oct 29, 2026 · 4:30 PM ET

    Register

Replays

  • Gilead Sciences (NASDAQ:GILD) Q2 2026 Earnings Call

    Tue, Aug 04, 2026 · 4:30 PM ET

    Watch Transcript

  • Gilead Sciences (NASDAQ:GILD) Q1 2026 Earnings Call

    Thu, May 07, 2026 · 4:30 PM ET

    Watch Transcript

  • Gilead Sciences (NASDAQ:GILD) Q4 2025 Earnings Call

    Tue, Feb 10, 2026 · 4:30 PM ET

    Watch Transcript

Latest news

Gilead Sciences to Release Third Quarter 2026 Financial Results on Thursday, October 29, 2026

Oct 15, 2026

Latin America’s PAHO-Gilead HIV Prevention Deal Is a Victory for Civil Society, says AHF

Sep 17, 2026

Gilead Accelerates Global Access Planning for Investigational Once-Yearly Lenacapavir for HIV Prevention

Sep 16, 2026

Gilead and PAHO Announce Milestone Partnership to Accelerate Access to Twice-Yearly Lenacapavir for HIV Prevention Across Latin America and the Caribbean

Sep 15, 2026

Gilead Opens State-of-the-Art Research Center to Advance the Next Generation of Medicines

Sep 8, 2026

Breaks Ground on New Biologics Facility as Part of $32 Billion U.S. R&D and Manufacturing Investment

Aug 28, 2026

U.S. FDA Approves Gilead’s Bixlenvo™, a New Once-Daily Single Tablet Option for Virologically Suppressed Adults With HIV, Including Those on Complex Regimens

Aug 27, 2026

Gilead Sciences to Present at Upcoming Third Quarter 2026 Investor Conferences

Aug 26, 2026

European Commission Expands Role of Gilead’s Trodelvy® in First-Line Metastatic Triple-Negative Breast Cancer Across PD-L1 Status

Aug 24, 2026

Quarterly Report for Quarter Ending June 30, 2026 (Form 10-Q)

Aug 6, 2026

All Gilead Sciences, Inc. news

Decks

Gilead Sciences, Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
84 in the last 12 months · 365 in all · newest Oct 15, 2026 · oldest 2020
Calls
25 calls with a replay · 25 with a transcript · latest Aug 4, 2026
Decks
44 decks · latest Aug 4, 2026

Where Gilead Sciences, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:GILD · Home listingNASDAQUnited StatesUSD
gettex:GISgettexGermanyEUR
Tradegate:GISTradegateGermanyEUR
BCBA:GILD · This pageBCBAArgentinaARS
TSX:GILDTSXCanadaCAD
Xetra:GISXetraGermanyEUR
Cboe Canada:GILDCboe CanadaCanadaCAD
Milan:1GILDMilanItalyEUR
LS Exchange:885823LS ExchangeGermanyEUR
BMV:GILDBMVMexicoMXN
Lang & Schwarz:885823Lang & SchwarzGermanyEUR
Frankfurt:GISFrankfurtGermanyEUR
BCBA:GILDDBCBAArgentinaUSD
Stuttgart:GISStuttgartGermanyEUR
B3:GILD34B3BrazilBRL
BOATS:GILDBOATSUnited StatesUSD
SIX Swiss:GILDSIX SwissSwitzerlandCHF
LSIN:0QYQLSINUnited KingdomUSD
BIVA:GILDBIVAMexicoMXN
EUROTLX:4GILDEUROTLXItalyEUR
BCBA:GILDCBCBAArgentinaUSD
VIE:GILDViennaAustriaEUR
Dusseldorf:GISDusseldorfGermanyEUR
Munich:GISMunichGermanyEUR
Aquis:GISDAquisUnited KingdomEUR
BCS:GILDBCSChileUSD
Hamburg:GISHamburgGermanyEUR
BCS:GILDCLBCSChileCLP
Aquis:GISDAquisUnited KingdomEUR
BVL:GILDUSBVLPeruPEN
BX Swiss:GISBX SwissSwitzerlandCHF
BCBA:GILDBBCBAArgentinaARS
Frankfurt:GIS0FrankfurtGermanyEUR
Hanover:GISHanoverGermanyEUR
SIX Swiss:GILD.USDSIX SwissSwitzerlandUSD
Turquoise:GILDNTurquoiseUnited KingdomUSD
BCBA:GILD.CIBCBAArgentinaARS

Log in to ask 6ix AI your own questions about Gilead Sciences, Inc.